Effect Of Biomechanical Stimulation On Skeletal Health In Adolescent And Young Women With Anorexia Nervosa
- Conditions
- Anorexia Nervosa
- Interventions
- Device: Low-magnitude mechanical stimulation platform
- Registration Number
- NCT01100567
- Lead Sponsor
- Boston Children's Hospital
- Brief Summary
This study will evaluate the effects of a novel, non-pharmacologic intervention for the prevention of deleterious changes in bone density and strength in adolescents with anorexia nervosa (AN), a disease commonly treated with extended periods of bed rest and immobilization. The primary focus of the trial is to conduct a prospective short-term intervention to prevent an uncoupling of bone turnover in inpatients hospitalized for AN, and to determine the long-term effects of a biomechanical intervention on skeletal health in ambulatory adolescents with AN.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 101
- Age 11-25 years
- Diagnosis of anorexia nervosa based on DSM-IV criteria
- Female gender
- English-speaking
-
• Concomitant chronic diseases which affect bone health, such as cystic fibrosis, inflammatory bowel disease, celiac disease, renal disease, or diabetes mellitus
-
Use of medications known to affect bone metabolism in the last 3 months, such as:
- Glucocorticoid therapy (including inhaled steroids)
- Anticonvulsants
- Combined estrogen/progestin contraceptive agents (oral contraceptive pills)
-
Depot medroxyprogesterone (Depo-Provera) use in the last 12 months
-
Current pregnancy
-
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low-magnitude mechanical stimulation Low-magnitude mechanical stimulation platform Randomized to stand on LMMS platform 10 minutes/daily Placebo platform Low-magnitude mechanical stimulation platform Randomized to stand on placebo platform for 10 minutes/day
- Primary Outcome Measures
Name Time Method Change From Baseline in C-telopeptides Baseline to 5 days
- Secondary Outcome Measures
Name Time Method Change From Baseline in Bone Specific Alkaline Phosphatase baseline to 5 days
Trial Locations
- Locations (1)
Children's Hospital Boston
🇺🇸Boston, Massachusetts, United States